Osaic Holdings
SRPT icon

Osaic Holdings’s Sarepta Therapeutics SRPT Stock Holding History

Osaic Holdings’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2
Closed -$30 – 8155
2025
Q3 		$30 Hold
2
– – ﹤0.01% 7812
2025
Q2 		$105 Hold
2
– – ﹤0.01% 7560
2025
Q1 		$2.08K Hold
2
– – ﹤0.01% 6582
2024
Q4 		$10.4K Hold
2
– – ﹤0.01% 5788
2024
Q3 		$11.2K Hold
2
– – ﹤0.01% 5751
2024
Q2 		$17.8K Hold
2
– – ﹤0.01% 5419
2024
Q1 		$13.5K Buy
2
+1
+100% +$122 ﹤0.01% 5581
2023
Q4 		$4.82K Buy
+1
New +$96 ﹤0.01% 6193

Other funds holding SRPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Osaic Holdings's SRPT Position: Q1 2026 in Review

Osaic Holdings increased its Sarepta Therapeutics (SRPT) stake by 71% in Q1 2026, buying an estimated $74.1K and bringing the position to 9,259 shares worth $201K. The position accounts for ﹤0.01% of the portfolio, ranked #4129.

Osaic Holdings first reported a position in SRPT in Q1 2020 and has held it in 25 quarters since. The position peaked at $3.4M in Q1 2023. 340 funds tracked by Wall St. Rank hold SRPT as of Q1 2026.

  • Osaic Holdings held 9,259 shares of Sarepta Therapeutics worth $201K as of Q1 2026.
  • Osaic Holdings bought 3,830 Sarepta Therapeutics shares in Q1 2026, an estimated $74.1K.
  • Sarepta Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #4129 holding.
  • Osaic Holdings first reported a position in Sarepta Therapeutics in Q1 2020 and has held it in 25 quarters since.
  • Osaic Holdings's Sarepta Therapeutics position peaked at $3.4M in Q1 2023.
  • 340 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.